Ha Tay Pharmaceutical JSC Balance Sheet Health
Financial Health criteria checks 6/6
Ha Tay Pharmaceutical JSC has a total shareholder equity of ₫1,056.2B and total debt of ₫376.3B, which brings its debt-to-equity ratio to 35.6%. Its total assets and total liabilities are ₫1,765.5B and ₫709.3B respectively. Ha Tay Pharmaceutical JSC's EBIT is ₫75.1B making its interest coverage ratio -39.9. It has cash and short-term investments of ₫222.5B.
Key information
35.6%
Debt to equity ratio
₫376.27b
Debt
| Interest coverage ratio | -39.9x |
| Cash | ₫222.52b |
| Equity | ₫1.06t |
| Total liabilities | ₫709.29b |
| Total assets | ₫1.77t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DHT's short term assets (₫837.2B) exceed its short term liabilities (₫593.6B).
Long Term Liabilities: DHT's short term assets (₫837.2B) exceed its long term liabilities (₫115.7B).
Debt to Equity History and Analysis
Debt Level: DHT's net debt to equity ratio (14.6%) is considered satisfactory.
Reducing Debt: DHT's debt to equity ratio has reduced from 70.8% to 35.6% over the past 5 years.
Debt Coverage: DHT's debt is well covered by operating cash flow (77.8%).
Interest Coverage: DHT earns more interest than it pays, so coverage of interest payments is not a concern.